JP2016521684A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521684A5
JP2016521684A5 JP2016515094A JP2016515094A JP2016521684A5 JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5 JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016515094 A JP2016515094 A JP 2016515094A JP 2016521684 A5 JP2016521684 A5 JP 2016521684A5
Authority
JP
Japan
Prior art keywords
solution
hypochlorous acid
magnesium
amount
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016515094A
Other languages
English (en)
Japanese (ja)
Other versions
JP6416227B2 (ja
JP2016521684A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/039202 external-priority patent/WO2014190184A1/en
Publication of JP2016521684A publication Critical patent/JP2016521684A/ja
Publication of JP2016521684A5 publication Critical patent/JP2016521684A5/ja
Application granted granted Critical
Publication of JP6416227B2 publication Critical patent/JP6416227B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016515094A 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用 Expired - Fee Related JP6416227B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361826382P 2013-05-22 2013-05-22
US61/826,382 2013-05-22
PCT/US2014/039202 WO2014190184A1 (en) 2013-05-22 2014-05-22 Stabilized hypochlorous acid solution and use thereof

Publications (3)

Publication Number Publication Date
JP2016521684A JP2016521684A (ja) 2016-07-25
JP2016521684A5 true JP2016521684A5 (cg-RX-API-DMAC7.html) 2017-06-29
JP6416227B2 JP6416227B2 (ja) 2018-10-31

Family

ID=51934166

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016515094A Expired - Fee Related JP6416227B2 (ja) 2013-05-22 2014-05-22 安定化次亜塩素酸溶液及びその使用

Country Status (6)

Country Link
US (2) US9918477B2 (cg-RX-API-DMAC7.html)
EP (1) EP2999341B1 (cg-RX-API-DMAC7.html)
JP (1) JP6416227B2 (cg-RX-API-DMAC7.html)
CA (1) CA2913137A1 (cg-RX-API-DMAC7.html)
MX (1) MX373524B (cg-RX-API-DMAC7.html)
WO (1) WO2014190184A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085021A2 (en) 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing peritonitis with oxidative reductive potential water solution
MX373524B (es) 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.
MX2019015822A (es) 2017-06-28 2022-09-05 Collidion Inc Composiciones, metodos y usos para limpieza, desinfeccion y/o esterilizacion.
MX2020007533A (es) 2018-01-14 2021-01-15 Collidion Inc Composiciones, equipos, metodos y usos para la limpieza, desinfeccion, esterilizacion y/o tratamiento.
CA3130277A1 (en) 2019-02-20 2020-08-27 Biiosmart Technologies Llc Hypochlorous acid intravenous solution, preparation, and method of use thereof
LU101842B1 (en) 2020-06-08 2021-12-08 Arnaud Mainnemare Pharmaceutical Composition for treating or preventing lesions and infections in a mammal
US11097945B1 (en) 2020-11-04 2021-08-24 Cougar Creek Electrolysed Water, Llc Methods and systems for production of an aqueous hypochlorous acid solution
IT202000028082A1 (it) 2020-11-23 2022-05-23 Md Italy Srl Composizione, preparazione ed impiego di una miscela a base di bromo per l’igiene perioculare, il trattamento e la prevenzione delle blefariti

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100737951B1 (ko) * 1999-12-10 2007-07-13 가오가부시끼가이샤 살균제 조성물
JP3554749B2 (ja) * 2001-02-22 2004-08-18 株式会社アクシス 殺菌消毒剤
US9168318B2 (en) 2003-12-30 2015-10-27 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and methods of using the same
US20050139808A1 (en) 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
EP1702161A2 (en) 2003-12-30 2006-09-20 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution, processes for producing same and methods of using the same
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
CN101163492B (zh) 2005-03-23 2013-01-30 奥古露丝创新科学公司 利用氧化还原电位水溶液治疗2度和3度烧伤的方法
KR101523091B1 (ko) 2005-03-23 2015-05-26 오클루스 이노바티브 사이언시즈 인코포레이티드 산화 환원 전위 수용액을 사용한 피부 궤양의 치료 방법
WO2006119300A2 (en) 2005-05-02 2006-11-09 Oculus Innovative Sciences, Inc. Method of using oxidative reductive potential water solution in dental applications
WO2007085021A2 (en) 2006-01-20 2007-07-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing peritonitis with oxidative reductive potential water solution
EP2136819A1 (en) 2007-03-13 2009-12-30 Oculus Innovative Sciences, Inc. Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same
KR101781229B1 (ko) 2009-06-15 2017-09-22 오클루스 이노바티브 사이언시즈 인코포레이티드 차아염소산을 함유하는 용액 및 그의 사용 방법
US10265341B2 (en) 2009-07-30 2019-04-23 Sonoma Pharmaceuticals, Inc. Hydrogel formulation comprising oxidative reductive potential water
GB2488838A (en) 2011-03-11 2012-09-12 Biomimetics Health Ind Ltd A stable antimicrobial aqueous hypochlorous acid solution
MX373524B (es) 2013-05-22 2020-04-21 Sanfer Farma S A P I De C V Solución estabilizada de ácido hipocloroso y uso de la misma.

Similar Documents

Publication Publication Date Title
JP2016521684A5 (cg-RX-API-DMAC7.html)
JP2022075813A (ja) ジクアホソル含有点眼液
JP2014515737A5 (cg-RX-API-DMAC7.html)
JP2012067110A5 (cg-RX-API-DMAC7.html)
MX2020014000A (es) Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
MX2016006197A (es) Formulaciones de compuestos de azaindol.
RU2015126801A (ru) Фторид-стабильные цинкосодержащие композиции для ухода за полостью рта
JP2009523832A5 (cg-RX-API-DMAC7.html)
JP2010514799A5 (cg-RX-API-DMAC7.html)
RU2012155188A (ru) Композиции для ухода за полостью рта, устойчивые к микробному росту
BR112017007144A2 (pt) ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição.
CN104488957A (zh) 循环水系统用高效复合杀菌剂及其制备方法
EP4631569A3 (en) Alginate film comprising a triptan
MY161032A (en) Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
NZ605860A (en) Use of vitamin c, and chromium-free vitamin k or 2-methyl-1,4-naphthalendione, and compositions thereof for treating a polycystic disease
PH12015501793B1 (en) Bicyclic compounds
MY179783A (en) Substituted bicyclic compounds
MX2015016057A (es) Solucion estabilizada de acido hipocloroso y uso de la misma.
GB2529597A (en) An oxychlorine oral rinse composition
ZA202106768B (en) Triamterene or nolatrexed for use in the treatment of phenylketonuria
BR112014004111A2 (pt) peneira molecular de silicoaluminofosfato e método de produção da mesma
JP2013509378A5 (cg-RX-API-DMAC7.html)
JP2018511644A5 (cg-RX-API-DMAC7.html)
JP2015521598A5 (cg-RX-API-DMAC7.html)
CN105410021A (zh) 一种无刺激日用消毒水